Abdominal Obesity Metabolic Syndrome
Welcome,         Profile    Billing    Logout  
 28 Companies   52 Products   52 Products   61 Mechanisms of Action   3 Trials   843 News 


12345678910111213...1617»
  • ||||||||||  Trial completion, Phase classification, Enrollment change, Trial completion date, Trial primary completion date:  Resveratrol in Metabolic Syndrome: Effect on Platelet Hyper-reactivity and HDL Lipid Peroxidation (clinicaltrials.gov) -  Apr 20, 2019   
    P=N/A,  N=41, Completed, 
    N=270 --> 0 | Recruiting --> Withdrawn Enrolling by invitation --> Completed | Phase classification: P3 --> PN/A | N=118 --> 41 | Trial completion date: Dec 2018 --> Apr 2019 | Trial primary completion date: Jul 2018 --> Feb 2019
  • ||||||||||  rosuvastatin/telmisartan / Generic mfg.
    Enrollment change, Trial termination:  A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome (clinicaltrials.gov) -  Apr 12, 2019   
    P4,  N=55, Terminated, 
    Enrolling by invitation --> Completed | Phase classification: P3 --> PN/A | N=118 --> 41 | Trial completion date: Dec 2018 --> Apr 2019 | Trial primary completion date: Jul 2018 --> Feb 2019 N=204 --> 55 | Recruiting --> Terminated; Due to poor enrollment rate
  • ||||||||||  Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  Cross-Sectional Iloperidone IVGTT (clinicaltrials.gov) -  Mar 12, 2019   
    P=N/A,  N=37, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=60 --> 37 | Trial completion date: Dec 2015 --> May 2016 | Trial primary completion date: Dec 2015 --> May 2016
  • ||||||||||  Trial completion, Enrollment change, Trial completion date:  Normobaric Hypoxic Training and Metabolic Syndrome (clinicaltrials.gov) -  Mar 4, 2019   
    P=N/A,  N=27, Completed, 
    Recruiting --> Completed | N=60 --> 37 | Trial completion date: Dec 2015 --> May 2016 | Trial primary completion date: Dec 2015 --> May 2016 Active, not recruiting --> Completed | N=40 --> 27 | Trial completion date: Mar 2018 --> Jun 2018
  • ||||||||||  Trial completion:  Effect of Dietary Macronutrient Composition (clinicaltrials.gov) -  Feb 6, 2019   
    P=N/A,  N=24, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  valsartan / Generic mfg.
    Enrollment change, Trial withdrawal:  Regression of Fatty Heart by Valsartan Therapy (clinicaltrials.gov) -  Jan 17, 2019   
    P4,  N=0, Withdrawn, 
    Recruiting --> Completed | Trial primary completion date: Dec 2018 --> Jan 2018 N=28 --> 0 | Recruiting --> Withdrawn
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date:  Stress and Sugar Synergy (clinicaltrials.gov) -  Jan 16, 2019   
    P=N/A,  N=23, Completed, 
    N=28 --> 0 | Recruiting --> Withdrawn Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Dec 2016 | Trial primary completion date: Dec 2018 --> Dec 2016
  • ||||||||||  Trial completion, Enrollment change, Trial completion date, Trial initiation date, Trial primary completion date:  Effects of Prehabilitation in Gastric Cancer Patients With Metabolic Syndrome on Perioperative Outcome (clinicaltrials.gov) -  Dec 20, 2018   
    P=N/A,  N=82, Completed, 
    Trial primary completion date: Nov 2015 --> Nov 2016 Recruiting --> Completed | N=54 --> 82 | Trial completion date: Dec 2016 --> Feb 2018 | Initiation date: Dec 2015 --> Sep 2015 | Trial primary completion date: Dec 2016 --> Feb 2018
  • ||||||||||  Trial completion, Trial completion date:  Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD (clinicaltrials.gov) -  Dec 11, 2018   
    P1/2,  N=21, Completed, 
    Recruiting --> Completed | N=54 --> 82 | Trial completion date: Dec 2016 --> Feb 2018 | Initiation date: Dec 2015 --> Sep 2015 | Trial primary completion date: Dec 2016 --> Feb 2018 Active, not recruiting --> Completed | Trial completion date: Sep 2018 --> Dec 2018
  • ||||||||||  Trial completion, Trial completion date:  EFIGRO: Effect of Exercise on Hepatic Fat in Overweight Children (clinicaltrials.gov) -  Nov 16, 2018   
    P=N/A,  N=115, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Sep 2018 --> Dec 2018 Recruiting --> Completed | Trial completion date: Jun 2018 --> Jan 2018
  • ||||||||||  metformin / Generic mfg.
    Trial completion, Trial completion date, Trial primary completion date:  Endogenous Opioid Activity and Affective State in Insulin Resistant Women (clinicaltrials.gov) -  Nov 8, 2018   
    P4,  N=42, Completed, 
    Recruiting --> Completed | Trial completion date: Jun 2018 --> Jan 2018 Active, not recruiting --> Completed | Trial completion date: Dec 2022 --> Sep 2017 | Trial primary completion date: Dec 2019 --> Mar 2017
  • ||||||||||  eplerenone / Generic mfg.
    Enrollment change, Trial termination:  Aldosterone Antagonism and Microvascular Function (clinicaltrials.gov) -  Nov 5, 2018   
    P4,  N=25, Terminated, 
    Active, not recruiting --> Completed | Trial completion date: Dec 2022 --> Sep 2017 | Trial primary completion date: Dec 2019 --> Mar 2017 N=60 --> 25 | Recruiting --> Terminated; Failure to recruit sufficient participants
  • ||||||||||  Trial completion:  Women's Lifestyle Balance Study (clinicaltrials.gov) -  Oct 25, 2018   
    P=N/A,  N=26, Completed, 
    N=60 --> 25 | Recruiting --> Terminated; Failure to recruit sufficient participants Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Phase classification, Trial completion date:  Resveratrol and the Metabolic Syndrome (clinicaltrials.gov) -  Oct 24, 2018   
    P=N/A,  N=28, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Phase classification: P2 --> PN/A | Trial completion date: Dec 2018 --> Jul 2018
  • ||||||||||  eplerenone / Generic mfg.
    Trial primary completion date:  Aldosterone Antagonism and Microvascular Function (clinicaltrials.gov) -  Oct 11, 2018   
    P4,  N=60, Recruiting, 
    Not yet recruiting --> Completed Trial primary completion date: Jun 2018 --> Nov 2018
  • ||||||||||  Trial completion, Phase classification, Enrollment change, Trial completion date, Trial primary completion date:  Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study (clinicaltrials.gov) -  Aug 30, 2018   
    P3,  N=8, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Feb 2018 --> Aug 2018 Recruiting --> Completed | Phase classification: PN/A --> P3 | N=40 --> 8 | Trial completion date: Nov 2016 --> Jun 2018 | Trial primary completion date: Nov 2016 --> Jun 2018
  • ||||||||||  Biomarker, Trial completion, Trial completion date, Trial primary completion date:  NUTREND: Development of Endothelial Biomarkers (clinicaltrials.gov) -  Aug 28, 2018   
    P=N/A,  N=60, Completed, 
    Recruiting --> Completed | Phase classification: PN/A --> P3 | N=40 --> 8 | Trial completion date: Nov 2016 --> Jun 2018 | Trial primary completion date: Nov 2016 --> Jun 2018 Recruiting --> Completed | Trial completion date: Oct 2016 --> Sep 2017 | Trial primary completion date: Aug 2016 --> Dec 2016
  • ||||||||||  Enrollment closed, Phase classification, Trial completion date, Trial primary completion date:  Effect of Implantable Contraception on Type-2 DM and Metabolic Syndrome in Women With History of Gestational DM (clinicaltrials.gov) -  Aug 22, 2018   
    P=N/A,  N=260, Active, not recruiting, 
    Recruiting --> Completed | Trial completion date: Oct 2016 --> Sep 2017 | Trial primary completion date: Aug 2016 --> Dec 2016 Recruiting --> Active, not recruiting | Phase classification: P2 --> PN/A | Trial completion date: Mar 2016 --> Jun 2022 | Trial primary completion date: Mar 2016 --> Mar 2017
  • ||||||||||  Trial completion date:  Resveratrol and the Metabolic Syndrome (clinicaltrials.gov) -  Apr 2, 2018   
    P2,  N=28, Active, not recruiting, 
    N=20 --> 0 | Active, not recruiting --> Withdrawn Trial completion date: Dec 2017 --> Dec 2018
  • ||||||||||  Trial completion:  Metasperme: Metabolic Syndrome and Male Infertility (clinicaltrials.gov) -  Mar 19, 2018   
    P=N/A,  N=170, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Sep 2018 --> Mar 2018 | Trial primary completion date: Sep 2018 --> Mar 2018 Active, not recruiting --> Completed
  • ||||||||||  ethinyl estradiol/norgestimate / Generic mfg.
    Trial completion date:  Oral Contraceptives in the Metabolic Syndrome (clinicaltrials.gov) -  Mar 12, 2018   
    P4,  N=36, Active, not recruiting, 
    Active, not recruiting --> Completed Trial completion date: Dec 2017 --> Apr 2018
  • ||||||||||  Trial completion, Trial primary completion date:  Oral Nitrite in Adults With Metabolic Syndrome and Hypertension (clinicaltrials.gov) -  Mar 7, 2018   
    P2,  N=20, Completed, 
    Trial completion date: Dec 2017 --> Apr 2018 Recruiting --> Completed | Trial primary completion date: Dec 2017 --> Feb 2018
  • ||||||||||  Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  China Action on Spine and Hip Status (clinicaltrials.gov) -  Mar 6, 2018   
    P=N/A,  N=3457, Completed, 
    Recruiting --> Completed | Trial primary completion date: Dec 2017 --> Feb 2018 Recruiting --> Completed | N=5000 --> 3457 | Trial completion date: Dec 2017 --> Jul 2017 | Trial primary completion date: Jun 2017 --> Jul 2017
  • ||||||||||  Enrollment closed, Trial completion date, Trial primary completion date:  Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD (clinicaltrials.gov) -  Mar 6, 2018   
    P1/2,  N=21, Active, not recruiting, 
    Recruiting --> Completed | N=5000 --> 3457 | Trial completion date: Dec 2017 --> Jul 2017 | Trial primary completion date: Jun 2017 --> Jul 2017 Recruiting --> Active, not recruiting | Trial completion date: Dec 2017 --> Sep 2018 | Trial primary completion date: Jun 2017 --> Apr 2018